Evidence map›Paper›PMID 42494142›Full record

ArticleActa physiologica (Oxford, England)2026

Renal Phosphate Reabsorption in Humans Depends on at Least Three Distinct Transporters Unlike in Mice.

Ashley L Fernandes, Laurine Lang, Jürgen Klar, Anja Giese, Alexander Ehrmann, Rupert Busch, Hannah Auwerx, Christoph Daniel, Nati Hernando, Isabel Rubio-Aliaga and 1 more

Abstract read
In one paragraph

Article in Acta physiologica (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ashley L FernandesInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Laurine LangInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0009-0006-2710-0847
Jürgen KlarCardiovascular, Renal and Immunology Research, Bayer AG, Wuppertal, Germany.
Anja GieseDrug Discovery Sciences, Bayer AG, Berlin, Germany.
Alexander EhrmannDrug Discovery Sciences, Bayer AG, Wuppertal, Germany.
Rupert BuschInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Hannah AuwerxInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Christoph DanielDepartment of Nephropathology, Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, Erlangen, Germany.
Nati HernandoInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Isabel Rubio-AliagaInstitute of Physiology, University of Zurich, Zurich, Switzerland.
Carsten A WagnerInstitute of Physiology, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-9874-8898

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 212303
6 · The paper itself

Abstract

aimKidney excretion of phosphate is the gatekeeper of systemic phosphate homeostasis as evident from inborn and acquired diseases. Renal phosphate transporters are a promising target for phosphate-lowering drugs, but molecular details of human kidney phosphate handling are largely unknown. Here, we aim to understand the dependency of renal phosphate transport on species, age, and sex.

methodsWe used a combination of transporter-specific inhibitors and radioactive flux measurements in isolated BBM vesicles prepared from human and murine kidneys. We included human female and male neonates (0-11 months) and adults (51-63 years) and age-matched mouse kidneys. Immunoblotting and immunofluorescence detected transport protein expression, and transcript expression was analyzed in publicly available data.

findingsThe flux experiments revealed that in human kidneys SLC34A1, SLC34A2/3 and other non-SLC34 transporter are active and expressed with age- and sex-dependent differences. In mice about 80% of renal phosphate handling depends on Slc34a1, but in humans SLC34A1 contribution is 60% in neonates and only 40% in adults. SLC34A3 contribution accounts for 20% in human neonates and 40% in human adults but is almost negligible in mice. Non SLC34 sodium-dependent phosphate transport was around 20% in all groups. SCRNA-seq data and immunoblotting analysis revealed differences in sodium cotransporters between species that supported the activity measurements.

conclusionOur data provide the first direct measurement of sodium-phosphate cotransporter activities in human kidney and show profound differences between species. These results are critical when developing novel drugs to modulate renal phosphate reabsorption.

Indexed as

KidneyPhosphatesRenal ReabsorptionSodium-Phosphate Cotransporter Proteins, Type IIaSodium-Phosphate Cotransporter Proteins, Type IIIAnimalsFemaleHumansInfantInfant, NewbornMaleMiceMiddle AgedPhosphatesSLC34A1 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIaSodium-Phosphate Cotransporter Proteins, Type IIIhuman renal brush border membrane vesiclesrenal phosphate cotransporterSLC34A1SLC34A3

Identifiers

PMID42494142
PMCPMC13396815

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.